Glenmark Pharmaceuticals  and Grandpharma  Companies Entered into Agreement

Glenmark Pharmaceuticals and Grandpharma Companies Entered into Agreement

February 6, 2019 323

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Grandpharma (China) Co. Ltd. for commercializing its novel nasal spray Ryaltris in China.

The agreement with Grandpharma is Glenmark’s third regional licensing deal for Ryaltris. Glenmark has already signed licensing deals for commercializing Ryaltris in Australia, New Zealand and South Korea.

Ryaltris [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel, investigational, fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age.

http://glenmarkpharma.com/sites/default/files/glenmark-pharma-enters-into-an-exclusive-license-agreement-with-grandpharma-for-commercializing-ryaltris-in-china.pdf

Under the terms of the agreement, Glenmark will be responsible to manufacture and supply Ryaltris, while Grandpharma will be responsible for regulatory filing and commercialization of Ryaltris in China. Glenmark will receive an upfront payment, regulatory filing, regulatory approval and commercial milestone payments as well as royalties from Grandpharma for Ryaltris.

We are happy to partner with Grandpharma in China as its product portfolio complements well with Ryaltris and this partnership gives us an opportunity to tap into one of the largest pharmaceutical markets in the world. This step is aligned with our vision to make Ryaltris the first global brand of Glenmark through launches in multiple markets across the globe,

said Glenn Saldanha, Chairman
and Managing Director of Glenmark Pharmaceuticals

 

 

 

Information source: https://gmpnews.net/2019/02/swiss-and-china-companies-entered-into-agreement/

Block ?

If this page is in your subscriptions, then it will be removed. You will not see this page. If you want to unblock a user, go to the settings, the list of blocked users and click unblock

Complain

The user will not know who exactly sent the complaint

Delete Company

The user will not know who exactly sent the complaint

Notifications

You Have 112 readed notifications

CHATS

Select chat category

×